Company Position Country
EMBLEM TECHNOLOGY TRANSFER GMBH Managing Director Germany
Session
IS EXTERNALISING THE TECH TRANSFER FUNCTION FOR ACADEMIC INSTITUTIONS A KEY TO SUCCEED?

Gábor M. LAMM, PhD
Dr. Lamm (born 1967 in Budapest) is a graduate of Edinburgh University (Biochemistry) and holds a Ph.D. in Molecular Biology.
After spending three years as a research scientist at the Boehringer Ingelheim Institute of Molecular Pathology (IMP) in Vienna, Dr. Lamm joined Wacker Chemie, a major global supplier of silicone and polymer raw materials and semi-conductors. At Wacker Chemie Dr. Lamm was Business-Team Leader in the division specialising in advanced ceramic components for high-tech applications. As of October 2000 he is Managing Director of EMBL Enterprise Management Technology Transfer GmbH (EMBLEM), a 100% subsidiary of the European Molecular Biology Laboratory (EMBL; http://www.embl.org).
Dr. Lamm is an alumnus of the European Molecular Biology Laboratory Ph.D. program and of the Boehringer Ingelheim Fonds, on the advisory board of various associations and start-up companies, co-founder of the VC vehicle EMBL-Ventures, and former vice-president (2002-2006) of the Association of European Science and Technology Transfer Professionals (ASTP).
About EMBLEM (http://www.embl-em.de)
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). EMBL, established in 1974, is a basic research institute funded by public research funds from over 20 member states, including most of the EU, Switzerland and Israel as well as Australia and Argentina as an associated member state. EMBLEM identifies, protects and commercialises the intellectual property developed in the EMBL-world and from third parties including the Life Science faculties of the University of Heidelberg. EMBLEM facilitates and accelerates the transfer of innovative technology from basic research to industry by working closely with industrial partners spanning the biotech, pharmaceutical, IT and mechanical/electrical engineering markets.


Continue your tour